In the multivariate analysis, the TG/HDL ratio (OR: 1.12, 95% CI: 1.05–1.19), FIB-4 (OR: 2.08, 95% CI: 1.64–2.64), the APRI (OR: ~0, 95% CI: not estimable due to model limitations), and the ALT/AST ratio (OR: 4.27, 95% CI: 3.36–5.41) remained independently associated with NAFLD (Table 3). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.